Information Provided By: 
Fly News Breaks for April 17, 2018
HOLX
Apr 17, 2018 | 10:13 EDT
Evercore ISI analyst Vijay Kumar called LightRx Face & Body signing an agreement to provide SculpSure for body contouring a "big win" for Hologic, as he believes it negates the thesis that Cynosure's products are not competitive. Given sentiment on Hologic being "at an all-time low," Kumar expects the stock to react positively to this announcement. The analyst, who estimates that LightRx could be a roughly $14 M revenue opportunity, keeps an Outperform rating on Hologic shares.
News For HOLX From the Last 2 Days
There are no results for your query HOLX
